STO’s Mission Advisory Board (MAB) is a distinguished group of global leaders from government, academia, and industry whose deep expertise across policy, advocacy, research, technology, and finance guide the organization’s vision and strategy for mission-critical activities.

The MAB plays a central role in shaping STO’s overall strategy to maximize its global impact through the discovery and examination of emerging trends and opportunities in policy, advocacy, research, technology, and finance in cancer care. Members of the MAB add tensile strength to the collective resolve of the organization, providing guidance on creative solutions that can facilitate optimal execution of strategic priorities.

The HARMONY initiative is guided by the MAB, with their insights and guidance ensuring that HARMONY remains forward-thinking, action-oriented, and positioned to make meaningful, lasting impact in cancer care across the globe.

Sean Khozin, MD, MPH

Co-Chairman, Mission Advisory Board

Mace L. Rothenberg, MD, FACP

Co-Chairman, Mission Advisory Board

Agnès Binagwaho, MD, M(Ped), PhD

John Cahill
John Crumpler, AB
Thomas J. Donohue

August 12, 1938 – October 14, 2024

James L. Gulley, MD, PhD, FACP
Zhi Hong, PhD
Kenneth B. Lee, Jr., MBA
François Maisonrouge, MBA, MS
Névine Zariffa, MMath
Helmut Zodl, MS